Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009861

CEO and Chairman sold 11,120 shares at $31.56 ($350,947)

  • CEO and Chairman acquired 11,120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-13 Exercise or conversion : show line 1 in the form +11,120 $0.33 $3,670 1,889,300 D
2020-02-13 Sale : show line 2 in the form −11,120 $31.56 $350,947 1,878,180 D
Open-market sales · 11,120 sh · avg $31.56 · $350,947

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-13 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −11,120 713,280 D
2020-02-13 Grant or award : show line 4 in the form Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/doc4.xml…